David L. Fitzgerald

Array ( [id] => 3418144 [patent_doc_number] => 05393870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-28 [patent_title] => 'Analogs of human granulocyte-macrophage colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/067934 [patent_app_country] => US [patent_app_date] => 1993-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8960 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/393/05393870.pdf [firstpage_image] =>[orig_patent_app_number] => 067934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873799 [patent_doc_number] => 05747278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'DNA encoding inward rectifier, G-protein activated, mammalian, potassium KGA channel and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/066371 [patent_app_country] => US [patent_app_date] => 1993-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 9187 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747278.pdf [firstpage_image] =>[orig_patent_app_number] => 066371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3088359 [patent_doc_number] => 05312628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-17 [patent_title] => 'Isolation of a soluble 42 KD pancreatic islet cell autoantigen' [patent_app_type] => 1 [patent_app_number] => 8/059719 [patent_app_country] => US [patent_app_date] => 1993-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5497 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/312/05312628.pdf [firstpage_image] =>[orig_patent_app_number] => 059719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3823520 [patent_doc_number] => 05731166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them' [patent_app_type] => 1 [patent_app_number] => 7/987272 [patent_app_country] => US [patent_app_date] => 1993-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 11673 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731166.pdf [firstpage_image] =>[orig_patent_app_number] => 987272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3473757 [patent_doc_number] => 05427922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'DNA encoding a new angiotensin II type 1 receptor subtype and its expression' [patent_app_type] => 1 [patent_app_number] => 8/041219 [patent_app_country] => US [patent_app_date] => 1993-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9366 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/427/05427922.pdf [firstpage_image] =>[orig_patent_app_number] => 041219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096140 [patent_doc_number] => 06096705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Inhibition of agonist-specific desensitization of .beta.2 adrenergic receptors' [patent_app_type] => 1 [patent_app_number] => 8/038072 [patent_app_country] => US [patent_app_date] => 1993-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 8863 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096705.pdf [firstpage_image] =>[orig_patent_app_number] => 038072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3453420 [patent_doc_number] => 05378614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast' [patent_app_type] => 1 [patent_app_number] => 8/026145 [patent_app_country] => US [patent_app_date] => 1993-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7046 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378614.pdf [firstpage_image] =>[orig_patent_app_number] => 026145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292118 [patent_doc_number] => 06197541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Recombinant thrombin receptors and assays using them' [patent_app_type] => 1 [patent_app_number] => 8/018760 [patent_app_country] => US [patent_app_date] => 1993-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14649 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197541.pdf [firstpage_image] =>[orig_patent_app_number] => 018760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604521 [patent_doc_number] => 05578707 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-26 [patent_title] => 'Soluble interferon-gamma receptor fragment' [patent_app_type] => 1 [patent_app_number] => 8/016992 [patent_app_country] => US [patent_app_date] => 1993-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5286 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 226 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/578/05578707.pdf [firstpage_image] =>[orig_patent_app_number] => 016992 [rel_patent_id] =>[rel_patent_doc_number] =>)